Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment

被引：0
作者：
Ruiwen Ruan
Li Li
Xuan Li
Chunye Huang
Zhanmin Zhang
Hongguang Zhong
Shaocheng Zeng
Qianqian Shi
Yang Xia
Qinru Zeng
Qin Wen
Jingyi Chen
Xiaofeng Dai
Jianping Xiong
Xiaojun Xiang
Wan Lei
Jun Deng
机构：
[1] First Affiliated Hospital of Nanchang University,Department of Oncology
[2] Jiangxi Key Laboratory for lndividualized Cancer Therapy,undefined
来源：
Molecular Cancer | / 22卷
关键词：
Fibroblast growth factor receptor; Immune checkpoint blockade; Tumor microenvironment; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade
    Chon, Hong Jae
    Lee, Won Suk
    Yang, Hannah
    Kong, So Jung
    Lee, Na Keum
    Moon, Eun Sang
    Choi, Jiwon
    Han, Eun Chun
    Kim, Joo Hoon
    Ahn, Joong Bae
    Kim, Joo Hang
    Kim, Chan
    CLINICAL CANCER RESEARCH, 2019, 25 (05) : 1612 - 1623
  • [32] Remodeling of the Tumor Microenvironment Through PAK4 Inhibition Sensitizes Tumors to Immune Checkpoint Blockade
    Abril-Rodriguez, Gabriel
    Torrejon, Davis Y.
    Karin, Daniel
    Campbell, Katie M.
    Medina, Egmidio
    Saco, Justin D.
    Galvez, Mildred
    Champhekar, Ameya S.
    Perez-Garcilazo, Ivan
    Baselga-Carretero, Ignacio
    Singh, Jas
    Comin-Anduix, Begona
    Puig-Saus, Cristina
    Ribas, Antoni
    CANCER RESEARCH COMMUNICATIONS, 2022, 2 (10): : 1214 - 1228
  • [33] Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment
    Zemek, Rachael M.
    De Jong, Emma
    Chin, Wee Loong
    Schuster, Iona S.
    Fear, Vanessa S.
    Casey, Thomas H.
    Forbes, Cath
    Dart, Sarah J.
    Leslie, Connull
    Zaitouny, Ayham
    Small, Michael
    Boon, Louis
    Forrest, Alistair R. R.
    Muiri, Daithi O.
    Degli-Esposti, Mariapia A.
    Millward, Michael J.
    Nowak, Anna K.
    Lassmann, Timo
    Bosco, Anthony
    Lake, Richard A.
    Lesterhuis, W. Joost
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (501)
  • [34] Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma
    Brown, Landon C.
    Zhu, Jason
    Desai, Kunal
    Kinsey, Emily
    Kao, Chester
    Lee, Yong Hee
    Pabla, Sarabjot
    Labriola, Matthew K.
    Tran, Jennifer
    Dragnev, Konstantin H.
    Tafe, Laura J.
    Dayyani, Farshid
    Gupta, Rajan T.
    McCall, Shannon
    George, Daniel J.
    Glenn, Sean T.
    Nesline, Mary K.
    George, Saby
    Zibelman, Matthew
    Morrison, Carl
    Ornstein, Moshe C.
    Zhang, Tian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (10)
  • [35] Immunosuppressive tumor microenvironment in occupational cholangiocarcinoma: Supportive evidence for the efficacy of immune checkpoint inhibitor therapy
    Sato, Yasunori
    Tanaka, Shogo
    Kinoshita, Masahiko
    Takemura, Shigekazu
    Shinkawa, Hiroji
    Kokudo, Takashi
    Hasegawa, Kiyoshi
    Tanaka, Hiromu
    Yoshimoto, Hidero
    Mori, Akira
    Yamamura, Minako
    Sasaki, Motoko
    Harada, Kenichi
    Kubo, Shoji
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2020, 27 (11) : 860 - 869
  • [36] Sharpening up tumor microenvironment to enhance the efficacy of immune checkpoint blockade on head and neck cancer using a CpG-oligodeoxynucleotide
    Tseng, Jen-Chih
    Yang, Jing-Xing
    Liu, Yi-Ling
    Su, Yu-Wen
    Lee, Alan Yueh-Luen
    Chen, Ya-Wen
    Liu, Ko-Jiunn
    Luo, Yunping
    Hong, Yi-Ren
    Chuang, Tsung-Hsien
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (05) : 1115 - 1128
  • [37] Sharpening up tumor microenvironment to enhance the efficacy of immune checkpoint blockade on head and neck cancer using a CpG-oligodeoxynucleotide
    Jen-Chih Tseng
    Jing-Xing Yang
    Yi-Ling Liu
    Yu-Wen Su
    Alan Yueh-Luen Lee
    Ya-Wen Chen
    Ko-Jiunn Liu
    Yunping Luo
    Yi-Ren Hong
    Tsung-Hsien Chuang
    Cancer Immunology, Immunotherapy, 2022, 71 : 1115 - 1128
  • [38] Prognostic Biomarker TP53 Mutations for Immune Checkpoint Blockade Therapy and Its Association With Tumor Microenvironment of Lung Adenocarcinoma
    Lin, Xinqing
    Wang, Liqiang
    Xie, Xiaohong
    Qin, Yinyin
    Xie, Zhanhong
    Ouyang, Ming
    Zhou, Chengzhi
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
  • [39] The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment
    Poon, Edmund
    Mullins, Stefanie
    Watkins, Amanda
    Williams, Geoffrey S.
    Koopmann, Jens-Oliver
    Di Genova, Gianfranco
    Cumberbatch, Marie
    Veldman-Jones, Margaret
    Grosskurth, Shaun E.
    Sah, Vasu
    Schuller, Alwin
    Reimer, Corrine
    Dovedi, Simon J.
    Smith, Paul D.
    Stewart, Ross
    Wilkinson, Robert W.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [40] Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy
    Hubert, Pascale
    Roncarati, Patrick
    Demoulin, Stephanie
    Pilard, Charlotte
    Ancion, Marie
    Reynders, Celia
    Lerho, Thomas
    Bruyere, Diane
    Lebeau, Alizee
    Radermecker, Coraline
    Meunier, Margot
    Nokin, Marie-Julie
    Hendrick, Elodie
    Peulen, Olivier
    Delvenne, Philippe
    Herfs, Michael
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (03)
12345